摘要 |
The present invention relates to the use of inhibitors or blockers of I<SUB>h</SUB> (hyperpolarization-activated cationic current) channels in the treatment of cognitive disorders. In preferred aspects of the present invention, an effective amount of a compound is administered to a patient in need, wherein the compound has the chemical structure: Where R<SUB>1</SUB> is H, or an optionally substituted C<SUB>1</SUB>-C<SUB>3</SUB> alkyl, preferably a C<SUB>2</SUB> alkyl (ethyl) group; R<SUP>2 </SUP>is an optionally substituted C<SUB>1</SUB>-C<SUB>3</SUB> alkyl group, preferably a methyl group; R<SUP>3</SUP> is H, an optionally substitutedC<SUB>1</SUB>-C<SUB>3</SUB> alkyl (preferably methyl), a halogen or 0(Ci-Ca) alkyl; R<SUP>4</SUP> is an optionally substituted C<SUB>1</SUB>-C<SUB>6</SUB> alkyl, C(O)-(C<SUB>1</SUB>-C<SUB>5</SUB>)alkyl, C(O)-aryl, C(O)O-(C<SUB>1</SUB>- C<SUB>4</SUB>)alkyl, C(O)O-aryl, or an optionally substituted heterocyclic, aryl or heteroaryl group; R<SUP>4</SUP>ais H or an optionally substituted C<SUB>1</SUB>-C<SUB>6</SUB> (preferably a C<SUB>1</SUB>-C<SUB>3</SUB>) alkyl; R<SUP>5</SUP>, R<SUP>6</SUP> and R<SUP>7</SUP> are each independently H, halogen, an optionally substituted C<SUB>1</SUB>-C<SUB>6</SUB> alkyl (preferably, an optionally substituted C<SUB>1</SUB>-C<SUB>3</SUB> alkyl), 0-(C<SUB>1</SUB>-C<SUB>3</SUB>) alkyl, or an optionally substituted heterocyclic, aryl or heteroaryl group; Y<SUP>-</SUP> is an anion of a pharmaceutically acceptable salt (a physiologically acceptable anion, preferably a Cl<SUP>-,</SUP> Br<SUP>-</SUP>, I<SUP>-</SUP>, OAc<SUP>-</SUP>); or a solvate or polymorph thereof, optionally, in combination with guanfacine and/or chelerythrine, and a pharmaceutically acceptable carrier, additive or excipient to a patient in need of therapy. |
申请人 |
YALE UNIVERSITY;ARNSTEN, AMY, F.T.;WANG, MIN;MCCORMICK, DAVID, A.;RAMOS, BRIAN, P. |
发明人 |
ARNSTEN, AMY, F.T.;WANG, MIN;MCCORMICK, DAVID, A.;RAMOS, BRIAN, P. |